Stocks To Buy Now

Blog


The Aristocrat Group Corp. (ASCC) Vodka-branded Race Car to Start in Pole Position

Today before the opening bell, the Aristocrat Group Corp. announced that its sponsored racecar will enter the Radical Cup Texas Round 4 race this weekend sitting in pole position. The RWB Vodka-branded car was declared the overall winner of the Radical Cup Round 3 event at NOLA Motorsports Park in New Orleans.

Select motorsports events have been key to ASCC’s marketing approach since RWB Vodka’s debut. RWB Vodka Racing’s SR3-RS car has taken a podium in every race entered and remains in the thick of the competition to become the season’s overall winner.

The RWB Vodka Racing team will compete against the field this weekend at MSR Houston in Angleton, Texas.

“At this point, the RWB Vodka car has won nearly as many trophies as the distilled spirit it represents,” said ASCC CEO Robert Federowicz. “We could not ask for a better brand ambassador in the world of motorsports.”

Having received 17 tasting awards over the past two years, RWB Ultra-Premium Handcrafted Vodka is among the most highly decorated American vodkas in the distilled spirits marketplace. It is the lynchpin of a growing portfolio of brands marketed and developed by the Aristocrat Group Corp. as the company works to capitalize on the rising commercial popularity of the domestic distilled spirits sector.

For more information on the Aristocrat Group Corp., visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.